The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Open accessAbstract
Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-gamma and type I IFN-alphabeta signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-alphabeta signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, it is no surprise that IFN-β transcriptome signatures were found to be associated with active but not latent TB (101).”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baechler, E. C., Batliwalla, F., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M. H., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,246
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L. B., Palucka, K., Arce, E., Cantrell, V., Borvák, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,990
Self-citationBlood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,744
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V. A., Dick, T., Ehrt, S., Flynn, J. L., Schnappinger, D., Wilkinson, R. J., & Young, D. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,441
Self-citationCell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,194
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 1,006
A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus
Chaussabel, D., Quinn, C., Shen, J., Patel, P., Glaser, C., Baldwin, N., Stichweh, D., Blankenship, D., Li, L., Munagala, I., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.012 · Cited by 649
Self-citationImmunisation against infectious disease
SALISBURY, D. M., Ramsay, M. E., & Noakes, K. (2006) · Stationery Office eBooks · Cited by 636
Newsom, S. W. B. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.003 · Cited by 636
Flagged first, then by citations
Research works printed but not linked: 2
- Dye, C., Floyd, K. & Uplekar, M. in Global Tuberculosis Control: Surveillance, Planning, Financing Ch. 1, 17–37 (World Health Organization, 2008)
- Falk, A. & O’Connor, J. B. in Diagnosis Standards and Classification of Tuberculosis, vol. 12 (eds Falk, A. et al.), 68–76 (National Tuberculosis and Respiratory Disease Association, 1969)
Cited by
Sorted by citations
Items 601–700 of 1,000
Menon, D., Singh, K., Pinto, S. M., Nandy, A., Jaisinghani, N., Kutum, R., Dash, D., Prasad, T. S. K., & Gandotra, S. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00301 · Cited by 50
Bartlett, S., Gemiarto, A. T., Ngo, M. D., Sajiir, H., Hailu, S. G., Sinha, R., Foo, C. X., Kleynhans, L., Tshivhula, H., Webber, T., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601534 · Cited by 47
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes
DiNardo, A. R., Gandhi, T., Heyckendorf, J., Grimm, S. L., Rajapakshe, K., Nishiguchi, T., Reimann, M., Kirchner, H. L., Kahari, J., Dlamini, Q., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02263-2021 · Cited by 47
The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome
Lai, R., Nakiwala, J. K., Meintjes, G., & Wilkinson, R. J. (2013) · European Journal of Immunology · doi:10.1002/eji.201343632 · Cited by 46
Self-citationXu, Y., Tan, Y., Zhang, X., Cheng, M., Hu, J., Liu, J., Chen, X., & Zhu, J. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.08.017 · Cited by 46
Wang, L., Ma, H., Wen, Z., Niu, L., Chen, X., Liu, H., Zhang, S., Xu, J., Zhu, Y., Li, H., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.09.004 · Cited by 46
Feng, S., McNehlan, M. E., Kinsella, R. L., Chowdhury, C. S., Chavez, S. M., Naik, S. K., McKee, S. R., Winkle, J. A. V., Dubey, N., Samuels, A. N., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01608-x · Cited by 46
Diagnosis and treatment of latent infection with M ycobacterium tuberculosis
Chee, C. B.-E., Sester, M., Zhang, W., & Lange, C. G. (2012) · Respirology · doi:10.1111/resp.12002 · Cited by 46
Rosa, R. D., de Lorgeril, J., Tailliez, P., Bruno, R., Piquemal, D., & Bachère, E. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-252 · Cited by 46
Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection
Travar, M., Petković, M. R., & Verhaz, A. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0365-7 · Cited by 47
de Araujo, L. S., Vaas, L. A. I., Alves, M. R., Geffers, R., Mello, F. C. D. Q., de Almeida, A. S., Moreira, A. D. S. R., Kritski, A. L., Silva, J. R. L. E., Moraes, M. O., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01586 · Cited by 46
Francisco, N. M., Fang, Y., Ding, L., Feng, S., Yang, Y., Wu, M., Jacobs, M., Ryffel, B., & Huang, X. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.09.012 · Cited by 46
Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action
Khan, S. R., Manialawy, Y. M., & Siraki, A. G. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14867 · Cited by 46
Genetics and evolution of tuberculosis pathogenesis: New perspectives and approaches
McHenry, M. L., Williams, S. M., & Stein, C. M. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104204 · Cited by 48
Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis
Wang, X., Jiang, J., Cao, Z., Yang, B., Zhang, J., & Cheng, X. (2012) · Tuberculosis · doi:10.1016/j.tube.2012.06.005 · Cited by 46
Killick, K. E., Browne, J. A., Park, S. D. E., Magee, D. A., Martin, I., Meade, K. G., Gordon, S. V., Gormley, E. P., O’Farrelly, C., Hokamp, K., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-611 · Cited by 48
Exploring the potential of adjunct therapy in tuberculosis
Rayasam, G. V., & Balganesh, T. S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.05.005 · Cited by 45
The Role of Host Genetics (and Genomics) in Tuberculosis
Naranbhai, V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0011-2016 · Cited by 45
Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis
Burel, J. G., Arlehamn, C. S. L., Khan, N., Seumois, G., Greenbaum, J., Taplitz, R., Gilman, R. H., Saito, M., Vijayanand, P., Sette, A., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800118 · Cited by 45
Burel, J. G., Babor, M., Pomaznoy, M., Arlehamn, C. S. L., Khan, N. A., Sette, A., & Peters, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00221 · Cited by 47
Estévez, O., Anibarro, L., Garet, E., Pallarés, Á., Barcia, L., Calviño, L., Maueia, C., Mussá, T., Fdez‐Riverola, F., Glez‐Peña, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01470 · Cited by 45
Xie, Y. L., Jager, V. R. D., Chen, R. Y., Dodd, L. E., Paripati, P., Via, L. E., Follmann, D. A., Wang, J., Lumbard, K., Lahouar, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd7618 · Cited by 45
Eribo, O. A., du Plessis, N., & Chegou, N. N. (2021) · Infection and Immunity · doi:10.1128/iai.00321-21 · Cited by 45
Toward a Unified Biosignature for TuberculosisPreprint
Maertzdorf, J., Kaufmann, S. H. E., & Weiner, J. M. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018531 · Cited by 45
Kinsella, R. L., Kimmey, J. M., Smirnov, A., Woodson, R., Gaggioli, M. R., Chavez, S. M., Kreamalmeyer, D., & Stallings, C. L. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002159 · Cited by 47
Mycobacterium tuberculosis Specific CD8+ T Cells Rapidly Decline with Antituberculosis Treatment
Nyendak, M. R., Park, B. S., Null, M. D., Baseke, J., Swarbrick, G. M., Mayanja‐Kizza, H., Nsereko, M., Johnson, D. F., Gitta, P., Okwera, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081564 · Cited by 44
Can early host responses to mycobacterial infection predict eventual disease outcomes?
de Silva, K., Begg, D. J., Plain, K. M., Purdie, A. C., Kawaji, S., Dhand, N. K., & Whittington, R. J. (2013) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2013.08.006 · Cited by 44
Raeven, R. H. M., Brummelman, J., Pennings, J. L. A., Nijst, O. E. M., Kuipers, B., Blok, L. E. R., Helm, K., van Riet, E., Jiskoot, W., van Els, C. A. C. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104548 · Cited by 45
Weiner, J. M., Maertzdorf, J., & Kaufmann, S. H. E. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06802.x · Cited by 44
Espezua, S., Villanueva, E., Maciel, C. D., & de Carvalho, A. C. P. L. F. (2014) · Neurocomputing · doi:10.1016/j.neucom.2014.07.057 · Cited by 44
Aricò, E., & Belardelli, F. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0077 · Cited by 44
Wareham, A., Tree, J. A., Marsh, P. D., Butcher, P. D., Dennis, M. J., & Sharpe, S. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088149 · Cited by 45
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection
Piñeros, A. R., Campos, L. W., da Fonseca, D. M., Bertolini, T. B., Gembre, A. F., Prado, R. Q., Alves-Filho, J. C., Ramos, S. G., Russo, M., & Bonato, V. L. D. (2017) · Scientific Reports · doi:10.1038/srep41240 · Cited by 44
Warren, E., Teskey, G., & Venketaraman, V. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020015 · Cited by 44
Type I Interferons, Autophagy and Host Metabolism in Leprosy
de Toledo-Pinto, T. G., Batista-Silva, L. R., Medeiros, R. C. A., Lara, F. A., & Moraes, M. O. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00806 · Cited by 44
Impact of Type I Interferons on Susceptibility to Bacterial Pathogens
Peignier, A., & Parker, D. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.01.007 · Cited by 44
Sandhu, V., Lothe, I. M. B., Labori, K. J., Lingjærde, O. C., Buanes, T. A., Dalsgaard, A. M., Skrede, M., Hamfjord, J., Haaland, T., Eide, T. J., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.002 · Cited by 43
Predictive markers of safety and immunogenicity of adjuvanted vaccines
Mastelic, B., Garçon, N., Giudice, G. D., Golding, H., Gruber, M. F., Neels, P., & Fritzell, B. (2013) · Biologicals · doi:10.1016/j.biologicals.2013.08.006 · Cited by 43
Seddon, J., Kasprowicz, V. O., Walker, N. F., Yuen, H. M., Sunpath, H., Tezera, L. B., Meintjes, G., Wilkinson, R. J., Bishai, W. R., Friedland, J. S., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit343 · Cited by 43
Self-citationCardona, P., Marzo, E., Tapia, G., Dı́az, J., Garcia, V. V., Varela, I., Vilaplana, C., & Cardona, P.-J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01482 · Cited by 43
Status of vaccine research and development of vaccines for tuberculosis
Evans, T. G., Schrager, L. E., & Thole, J. E. R. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.079 · Cited by 43
Domaszewska, T., Scheuermann, L., Hahnke, K., Mollenkopf, H., Dorhoi, A., Kaufmann, S. H. E., & Weiner, J. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-11812-x · Cited by 43
Thương, N. T. T., Vinh, D. N., Hai, H. T., Thu, D. D. A., Nhat, L. T. H., Heemskerk, D., Bang, N. D., Caws, M., Mai, N. T. H., & Thwaites, G. E. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy588 · Cited by 41
Wallihan, R. G., Suárez, N. M., Cohen, D. M., Marcon, M. J., Moore‐Clingenpeel, M., Mejías, A., & Ramilo, O. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00382 · Cited by 43
Self-citationChinta, K. C., Rahman, M. A., Saini, V., Glasgow, J. N., Reddy, V. P., Lever, J. M., Nhamoyebonde, S., Leslie, A. J., Wells, R. M., Traylor, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.073 · Cited by 43
Brazier, B., & McShane, H. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00794-0 · Cited by 43
Natarajan, S., Ranganathan, M., Hanna, L. E., & Tripathy, S. P. (2022) · Genes · doi:10.3390/genes13040616 · Cited by 43
Systems immunology of human malaria
Tran, T. M., Samal, B. B., Kirkness, E. F., & Crompton, P. D. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.03.006 · Cited by 46
Clinical Immunology and Multiplex Biomarkers of Human TuberculosisPreprint
Walzl, G., Haks, M. C., Joosten, S. A., Kleynhans, L., Ronacher, K., & Ottenhoff, T. H. M. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018515 · Cited by 43
Bromley, J. D., Ganchua, S. K. C., Nyquist, S. K., Maiello, P. A., Chao, M. C., Borish, H. J., Rodgers, M., Tomko, J. A., Kracinovsky, K. B., Mugahid, D., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.002 · Cited by 42
Mycobacterium tuberculosis virulence lipid PDIM inhibits autophagy in mice
Mittal, E., Prasad, G. V. R. K., Upadhyay, S., Sadadiwala, J., Olive, A. J., Yang, G., Sassetti, C. M., & Philips, J. A. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01797-5 · Cited by 42
Cardona, P.-J. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00612 · Cited by 42
Gonçalves, P., Guertler, C., Bachère, E., de Souza, C. R. B., Rosa, R. D., & Perazzolo, L. M. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.09.017 · Cited by 42
Heyckendorf, J., Olaru, I. D., Rühwald, M., & Lange, C. G. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0363pp · Cited by 44
Paquin‐Proulx, D., Greenspun, B. C., Costa, E. A. S., Segurado, A. A. C., Kallas, E. G., Nixon, D. F., & Leal, F. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175345 · Cited by 42
Reynés, B., Priego, T., Cifre, M., Oliver, P., & Palou, A. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12363 · Cited by 42
Illuminating Host-Mycobacterial Interactions with Genome-wide CRISPR Knockout and CRISPRi Screens
Lai, Y., Babunovic, G. H., Cui, L., Dedon, P. C., Doench, J. G., Fortune, S. M., & Lu, T. K. (2020) · Cell Systems · doi:10.1016/j.cels.2020.08.010 · Cited by 42
BloodGen3Module: blood transcriptional module repertoire analysis and visualization using R
Rinchai, D., Roelands, J. P., Toufiq, M., Hendrickx, W., Altman, M. C., Bedognetti, D., & Chaussabel, D. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab121 · Cited by 47
Self-citationHamada, Y., Penn‐Nicholson, A., Krishnan, S., Cirillo, D. M., Matteelli, A., Wyss, R., Denkinger, C. M., Rangaka, M. X., Rühwald, M., & Schumacher, S. G. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104174 · Cited by 42
Bah, S. Y., Morang’a, C. M., Kengne-Ouafo, J. A., Amenga-Etego, L. N.-K., & Awandare, G. A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00575 · Cited by 42
Krupka, M., Seydel, K. B., Feintuch, C. M., Yee, K., Kim, R. S., Lin, C., Calder, R. B., Petersen, C. A., Taylor, T. E., & Daily, J. P. (2012) · Infection and Immunity · doi:10.1128/iai.06008-11 · Cited by 41
Coincident Pre-Diabetes Is Associated with Dysregulated Cytokine Responses in Pulmonary Tuberculosis
Kumar, N. P., Banurekha, V. V., Nair, D., Sridhar, R., Kornfeld, H., Nutman, T. B., & Babu, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112108 · Cited by 41
How to use: interferon γ release assays for tuberculosis
Pollock, L., Roy, R. B., & Kampmann, B. (2013) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2013-303641 · Cited by 41
TLR2 Signaling Depletes IRAK1 and Inhibits Induction of Type I IFN by TLR7/9
Liu, Y. C., Simmons, D. P., Li, X., Abbott, D. W., Boom, W. H., & Harding, C. V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102181 · Cited by 41
de Toledo-Pinto, T. G., Ferreira, A. B. R., Alves, M. R., Rodrigues, L. S., Batista-Silva, L. R., Silva, B. J. D. A., Lemes, R. M. R., Martinez, A. N., Sandoval, F., Alvarado-Arnez, L. E., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw144 · Cited by 41
Clostridium difficile infection in diabetes
Qu, H., & Jiang, Z. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.06.002 · Cited by 41
Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review
Leo, S., Narasimhan, M., Rathinam, S., & Banerjee, A. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2386030 · Cited by 40
A vision and a prescription for big data–enabled medicine
Chaussabel, D., & Pulendran, B. (2015) · Nature Immunology · doi:10.1038/ni.3151 · Cited by 41
Self-citationNetwork approaches to drug discovery
Chandra, N. R., & Padiadpu, J. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.741119 · Cited by 42
Wu, L., Qin, Y., Xia, S., Dai, M., Han, X., Wu, Y., Zhang, X., Ma, J., Wang, Y., Tang, Y., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39543 · Cited by 40
Gideon, H. P., Skinner, J. A., Baldwin, N. E., Flynn, J. L., & Lin, P. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601138 · Cited by 40
Self-citationMackay, M. C., Oswald, M., Sánchez‐Guerrero, J., Lichauco, J. J., Aranow, C. B., Kotkin, S., Korsunsky, I., Gregersen, P. K., & Diamond, B. (2016) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000159 · Cited by 42
Getting “Inside” Type I IFNs: Type I IFNs in Intracellular Bacterial Infections
Snyder, D. T., Hedges, J. F., & Jutila, M. A. (2017) · Journal of Immunology Research · doi:10.1155/2017/9361802 · Cited by 43
Stratification of Latent Mycobacterium tuberculosis Infection by Cellular Immune Profiling
Halliday, A., Whitworth, H. S., Kottoor, S. H., Niazi, U. H. K., Menzies, S., Kunst, H., Bremang, S., Badhan, A., Beverley, P. C. L., Kon, O. M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix107 · Cited by 40
Self-citationAhmed, A., Adiga, V., Nayak, S., Kumar, J. A. J. U., Dhar, C., Sahoo, P. N., Sundararaj, B. K., Souza, G. D., & Vyakarnam, A. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007289 · Cited by 41
Delgobo, M., Mendes, D. A. G. B., Gonzalez‐Kozlova, E., da Rocha, E. L., Rodrigues-Luiz, G. F., Mascarin, L. Z., Dias, G. B. M., Patricio, D. D. O., Dierckx, T., Bicca, M. A., et al. (2019) · eLife · doi:10.7554/elife.47013 · Cited by 42
Dong, S. X. M., Caballero, R. E., Ali, H., Roy, D. L. F., Cassol, E., & Kumar, A. (2020) · RNA Biology · doi:10.1080/15476286.2020.1730081 · Cited by 40
Blood genome expression profiles in infants with congenital cytomegalovirus infection
Ouellette, C. P., Sánchez, P. J., Xu, Z., Blankenship, D., Zeray, F., Ronchi, A., Shimamura, M., Chaussabel, D., Lee, L. E., Owen, K. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17178-5 · Cited by 41
Self-citationAmorim, C. F., Novais, F. O., Nguyen, B. T., Nascimento, M. T., Lago, J., Lago, A. S., Carvalho, L. P., Beiting, D. P., & Scott, P. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009321 · Cited by 41
Bayaa, R., Ndiaye, M. D., Chedid, C., Kokhreidze, E., Tukvadze, N., Banu, S., Uddin, M. K. M., Biswas, S., Nasrin, R., Ranaivomanana, P. P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93059-1 · Cited by 40
Kang, T. G., Kwon, K. W., Kim, K. S., Lee, I., Kim, M. J., Ha, S., & Shin, S. J. (2022) · Nature Communications · doi:10.1038/s41467-022-30914-3 · Cited by 40
Mahajan, P., Kuppermann, N., Suárez, N. M., Mejías, A., Casper, C., Dean, J. M., & Ramilo, O. (2014) · Pediatric Emergency Care · doi:10.1097/pec.0000000000000324 · Cited by 40
Self-citationMehraj, V., Textoris, J., Amara, A. B., Ghigo, É., Raoult, D., Capo, C., & Mège, J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit266 · Cited by 40
Genomics of Human Pulmonary Tuberculosis: from Genes to Pathways
Stein, C. M., Sausville, L. N., Wejse, C. M., Sobota, R. S., Zetola, N. M., Hill, P. C., Boom, W. H., Scott, W. K., Sirugo, G., & Williams, S. M. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0130-9 · Cited by 40
Cell-Autonomous Effector Mechanisms against Mycobacterium tuberculosisPreprint
MacMicking, J. D. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018507 · Cited by 42
Khaenam, P., Rinchai, D., Altman, M. C., Chiche, L., Buddhisa, S., Kewcharoenwong, C., Suwannasaen, D., Mason, M. J., Whalen, E., Presnell, S., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-65 · Cited by 39
Self-citationExcessive Cytolytic Responses Predict Tuberculosis Relapse After Apparently Successful Treatment
Cliff, J. M., Cho, J.-E., Lee, J., Ronacher, K., King, E. C., van Helden, P. D., Walzl, G., & Dockrell, H. M. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv447 · Cited by 39
Lindenstrøm, T., Moguche, A. O., Damborg, M., Agger, E. M., Urdahl, K. B., & Andersen, P. L. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.004 · Cited by 39
Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease
Zheng, X., O’Connell, C. M., Zhong, W., Nagarajan, U. M., Tripathy, M. K., Lee, D., Russell, A. N., Wiesenfeld, H. C., Hillier, S. L., & Darville, T. L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701658 · Cited by 42
Choudhary, R. K., Wall, K. M., Njuguna, I. N., Pavlinac, P. B., LaCourse, S. M., Otieno, V. O., Gatimu, J., Stern, J., Maleche‐Obimbo, E., Wamalwa, D. C., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001893 · Cited by 39
Banks, D. A., Ahlbrand, S. E., Hughitt, V. K., Shah, S., Mayer-Barber, K. D., Vogel, S. N., El-Sayed, N. M., & Briken, V. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801303 · Cited by 39
Neutrophil autophagy during human active tuberculosis is modulated by SLAMF1
Pellegrini, J. M., Sabbione, F., Morelli, M. P., Tateosian, N. L., Castello, F. A., Amiano, N. O., Palmero, D., Levi, A., Ciallella, L. M., Colombo, M. I., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1825273 · Cited by 39
Xu, W., Snell, L. M., Guo, M., Boukhaled, G. M., Macleod, B. L., Li, M., Tullius, M. V., Guidos, C. J., Tsao, M., Divangahi, M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.003 · Cited by 40
Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
Stegelmeier, A. A., Darzianiazizi, M., Hanada, K., Sharif, S., Wootton, S. K., Bridle, B. W., & Karimi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094726 · Cited by 41
Reichmann, M. T., Tezera, L. B., Vallejo, A. F., Vukmirovic, M., Xiao, R., Reynolds, J., Jogai, S., Wilson, S. C., Marshall, B. G., Jones, M. G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148136 · Cited by 39
Transcriptomics for child and adolescent tuberculosis*
Kaforou, M., Broderick, C. M., Vito, O., Levin, M., Scriba, T. J., & Seddon, J. A. (2022) · Immunological Reviews · doi:10.1111/imr.13116 · Cited by 39
Rao, A., Popper, S. J., Gupta, S., Davong, V., Vaidya, K., Chanthongthip, A., Dittrich, S., Robinson, M. T., Vongsouvath, M., Mayxay, M., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100842 · Cited by 40
Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis
Zambuzi, F. A., Cardoso-Silva, P. M., Espíndola, M. S., Soares, L. S., Galvão-Lima, L. J., Brauer, V. S., Gomes, M. D. S., do Amaral, L. R., Schaller, M. A., Bóllela, V. R., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.08.030 · Cited by 39
Dawany, N. B., Showe, L. C., Kossenkov, A. V., Chang, C., Ive, P., Conradie, F., Stevens, W. S., Sanne, I., Azzoni, L., & Montaner, L. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089925 · Cited by 38
Systems approaches to studying the immune response in tuberculosis
Berry, M. P. R., Blankley, S., Graham, C. M., Bloom, C. I., & O’Garra, A. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.08.003 · Cited by 38
Self-citation
Metadata
- Authors
- Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., Quinn, C., Blankenship, D., Dhawan, R., Cush, J. J., Mejias, A., Ramilo, O., Kon, O. M., Pascual, V., Banchereau, J., Chaussabel, D., & O’Garra, A.
- Affiliations
- National Institute for Medical Research (GB)
- Inserm (FR)
- Imperial College Healthcare NHS Trust (GB)
- University of Cape Town (ZA)
- The University of Texas Southwestern Medical Center (US)
- Baylor Scott & White Health (US)
- Nationwide Children's Hospital (US)
- Corresponding author
- O’Garra, Anne
- ORCID
- Venue
- Nature
- Published
- 2010-08
- Volume
- 466
- Issue
- 7309
- Pages
- 973-977
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3492754
- OpenAlex
- W2109543073
- Cited by
- 1,898
- References
- 29
- Citations by year
- 2026: 104 · 2025: 105 · 2024: 112 · 2023: 108 · 2022: 99 · 2021: 121 · 2020: 113 · 2019: 127 · 2018: 137 · 2017: 134 · 2016: 149 · 2015: 126 · 2014: 119 · 2013: 127 · 2012: 114
- FWCI
- 70.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust (088316, 84323)
- Imperial College Healthcare NHS Trust
- U.S. Public Health Service (U19 AIO57234-02, P50 ARO54083)
- Medical Research Council
- National Cancer Institute (P01CA084512)
- National Institute of Allergy and Infectious Diseases (U19AI057234, U01AI082110, U19AI082715)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR050770, P50AR054083)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- tuberculosis, Mycobacterium tuberculosis, latent tuberculosis infection, active tuberculosis, whole blood transcriptome, interferon-stimulated genes, neutrophils, interferon-gamma signaling, type I interferon, transcriptomic biomarkers, diagnostic biomarkers, prognostic factors, systemic lupus erythematosus, cell composition, treatment response monitoring
- MeSH terms
- Blood, Gene Expression Regulation, Humans, Interferon Type I, Lupus Erythematosus, Systemic, Mycobacterium tuberculosis, Neutrophils, Transcription, Genetic, Tuberculosis, Tuberculosis, Pulmonary, Signal Transduction, Case-Control Studies, Gene Expression Profiling, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review